Unexpected maintenance of hepatitis c viral diversity following liver transplantation

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8432-8439

  Gray, Rebecca R ^a   Strickland, Samantha L ^b   Veras, Nazle M ^b   Goodenow, Maureen M ^b,c   Pybus, Oliver G ^a   Lemon, Stanley M ^d   Fried, Michael W ^d   Nelson, David R ^b,c   Salemib, Marco ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION STRUCTURE; PRIORITY JOURNAL; REINFECTION; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS EXAMINATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADULT; AGED; CLUSTER ANALYSIS; GENETIC VARIATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 84865085855     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00749-12     Document Type: Article

References (50)

1. Allain JP, Dong Y, Vandamme AM, Moulton V, Salemi M. 2000. Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters. J. Virol. 74:2541-2549.
2. Arenas JI, et al. 2004. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J. Infect. Dis. 189:2037-2046.
3. Centers for Disease Control and Prevention. 2010. Hepatitis C FAQs for the public. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hepatitis/C/cFAQ.htm.
4. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214. doi:10.1186/1471-2148-7-214.
5. Drummond AJ, Rambaut A, Shapiro B, Pybus OG. 2005. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22:1185-1192.
6. Ducoulombier D, et al. 2004. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39: 817-825.
7. Edwards CT, et al. 2006. Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. BMC Evol. Biol. 6:28. doi:10.1186/1471-2148-6-28.
8. Fafi-Kremer S, et al. 2010. Viral entry and escape from antibodymediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. 207:2019-2031.
9. Feliu A, Gay E, Garcia-Retortillo M, Saiz JC, Forns X. 2004. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl. 10:1131-1139.
10. Fletcher NF, et al. 2012. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634-643.e636.
11. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. 2002. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122:889-896.
12. Gane EJ, et al. 1996. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110:167-177.
13. Gray RR, et al. 2011. The mode and tempo of hepatitis C virus evolution within and among hosts.BMCEvol. Biol. 11:131. doi:10.1186/1471-2148-11-131.
14. Gretch DR, et al. 1996. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70:7622-7631.
15. Guindon S, Delsuc F, Dufayard J, Gascuel O. 2009. Estimating maximum-likelihood phylogenies with PhyML. Methods Mol. Biol. 537:113-137.
16. Hughes MG, Jr, et al. 2004. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Liver Transpl. 10:208-216.
17. Ina Y, Mizokami M, Ohba K, Gojobori T. 1994. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J. Mol. Evol. 38:50-56.
18. Keck ZY, et al. 2008. Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies. J. Virol. 82:6061-6066.
19. Keck ZY, et al. 2011. Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations. J. Virol. 85:10451-10463.
20. Kosakovsky-Pond SL, Frost SD. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22:1208-1222.
21. Kuntzen T, et al. 2008. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatmentnaive patients. Hepatology 48:1769-1778.
22. Laskus T, et al. 2002. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 76:10064-10068.
23. Laskus T, et al. 2004. Human immunodeficiency virus facilitates infection/ replication of hepatitis C virus in native human macrophages. Blood 103:3854-3859.
24. Laskus T, et al. 2000. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J. Infect. Dis. 181:442-448.
25. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. 2002. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J. Infect. Dis. 185:417-421.
26. Levrero M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847.
27. Li H, et al. 2010. Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology 402:248-255.
28. Massaguer A, et al. 2007. Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation. Am. J. Transplant. 7:2172-2179.
29. McHutchison JG, et al. 2009. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N. Engl. J. Med. 360:1827-1838.
30. Meuleman P, Leroux-Roels G. 2009. HCV animal models: a journey of more than 30 years. Viruses 1:222-240.
31. Mitchell-Olds T, Willis JH, Goldstein DB. 2007. Which evolutionary processes influence natural genetic variation for phenotypic traits? Nat. Rev. Genet. 8:845-856.
32. Moreno-Garcia J, et al. 2003. Analysis of hepatitis C viral quasispecies in liver transplantation. Transplant Proc. 35:1838-1840.
33. Pond S, Frost S. 2005. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21:2531-2533.
34. Powers KA, et al. 2006. Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl. 12:207-216.
35. Pybus OG, Rambaut A, Harvey PH. 2000. An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155:1429-1437.
36. Radkowski M, et al. 2004. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J. Gen. Virol. 85:47-59.
37. Ramirez S, et al. 2009. Hepatitis C virus compartmentalization and infection recurrence after liver transplantation. Am. J. Transplant. 9:1591-1601.
38. Rouzine IM, Coffin JM. 1999. Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl. Acad. Sci. U. S. A. 96:10758-10763.
39. Gray RR, Salemi M, Klenerman P, Pybus OG. 2012. A new evolutionary model for hepatitis C virus chronic infection. PLoS Pathog. 8:e1002656. doi:10.1371/journal.ppat.1002656.
40. Salemi M, Vandamme A. 2002. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 54:62-70.
41. Schramm F, et al. 2008. Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation. J. Infect. Dis. 198:1656-1666.
42. Schvoerer E, et al. 2007. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. J. Infect. Dis. 196:528-536.
43. Shirai M, et al. 1999. T cell recognition of hypervariable region-1 from hepatitisCvirus envelope protein with multiple class IIMHCmolecules in mice and humans: preferential help for induction of antibodies to the hypervariable region. J. Immunol. 162:568-576.
44. Steel MA, Hendy MD, Penny D. 1988. Loss of information in genetic distances. Nature 336:118.
45. Suchard MA, Weiss RE, Sincheimer JS. 2001. Bayesian selection of continuous-time Markov chain evolutionary models. Mol. Biol. Evol. 18: 1001-1013.
46. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
47. Thomas E, Fried MW. 2008. Hepatitis C: current options for nonresponders to peginterferon and ribavirin. Curr. Gastroenterol. Rep. 10: 53-59.
48. Urbani S, et al. 2001. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology 33:1533-1543.
49. Wang X, et al. 2007. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J. Virol. 81:6513-6522.
50. World Health Organization. 2010. HCV: surveillance and control. World Health Organization, Geneva, Switzerland. http://www.who.int/csr /disease/hepatitis/whocdscsrlyo2003/en/index4.html.